⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL212053 | 0.78 | HDAC3 (0.39) | — | |
| SCHEMBL9281844 | 0.72 | — | — | |
| SCHEMBL11785635 | 0.71 | ADRA2A (0.32) | — | |
| Hydrochloric Acid SCHEMBL8535633 | 0.70 | — | — | |
| SCHEMBL27760002 | 0.68 | — | — | |
| SCHEMBL28883338 | 0.67 | HDAC3 (0.33) | — | |
| SCHEMBL9669159 | 0.66 | — | — | |
| SCHEMBL14572844 | 0.65 | HDAC3 (0.32) | — | |
| SCHEMBL11126927 | 0.64 | HDAC3 (0.32) | — | |
| Allylamine SCHEMBL28106768 | 0.64 | ALDH1A1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306133-A1 | COMPOSITION FOR ADMINISTRATION OF DOUBLE-STRANDED OLIGONUCLEOTIDE STRUCTURES USING ULTRASONIC NEBULIZER FOR PREVENTION OR TREATMENT OF RESPIRATORY VIRAL INFECTION INCLUDING COVID-19, PULMONARY FIBROSIS CAUSED BY VIRAL INFECTION, OR RESPIRATORY DISEASES | Bioneer Corporation (KR) | 2024-01-17 | — | — | EP | disclosed |
| WO-2021229479-A1 | COMPOSITION FOR PREVENTING OR TREATING OBESITY-RELATED DISEASE CONTAINING AMPHIREGULIN-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE STRUCTURE | (주)바이오니아 | 2021-11-18 | — | — | WO | disclosed |